Last Updated on May 1, 2024 by The Health Master
USFDA approval
Caplin Steriles Limited, a subsidiary of Caplin Point Laboratories Limited, has secured a significant victory with the final USFDA approval for its Abbreviated New Drug Application (ANDA) for Ofloxacin Ophthalmic Solution USP 0.3%.
This represents a generic therapeutic equivalent to Allergan Inc.’s established brand, OCUFLOX Ophthalmic Solution.
Addressing a Widespread Eye Infection Need
The USFDA approved Ofloxacin Ophthalmic Solution USP 0.3% targets a prevalent eye infection concern: bacterial conjunctivitis.
This condition, commonly referred to as pink eye, causes inflammation and irritation of the conjunctiva, the thin membrane lining the eyelid and eyeball.
Furthermore, the solution is effective in treating bacterial corneal ulcers, which are open sores on the cornea, the eye’s transparent outer surface.
These ulcers can be incredibly painful and lead to vision problems if left untreated.
Capitalizing on a Lucrative Market
According to IQVIA (IMS Health), the market for Ofloxacin Ophthalmic Solution USP 0.3% in the United States is substantial.
In the 12-month period ending December 2023, the brand generated approximately $52 million in sales.
This highlights the significant opportunity Caplin Steriles has to gain a foothold in this high-revenue market with their generic alternative.
A Major Boost for Caplin Steriles
This USFDA approval marks a critical milestone for Caplin Steriles.
It not only expands their product portfolio in the ophthalmic segment but also positions them to cater to a large patient population suffering from bacterial conjunctivitis and corneal ulcers.
Additionally, the potential to tap into a multi-million dollar market in the US is a significant development for the company’s growth strategy.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
USFDA Approval granted for this Breast Cancer Drug: Alembic
USFDA approval granted for Fluoxetine Tablets
USFDA approval granted for First Generic Injection for Breast Cancer
USFDA approval granted for Migalastat Capsules
USFDA approval granted for Eslicarbazepine Acetate Tablets
USFDA approval granted for Mometasone Furoate Monohydrate Nasal Spray
India to finalise List of OTC Drugs
DCC: Take action to Curb Antimicrobial Resistance (AMR) in India
Govt Job: For Pharma Graduates as Junior Analyst (361) posts
Pakistan in Healthcare Crisis: Struggle to Afford Life-Saving Medicines
Golden Opportunity for Indian Generic Drugs: Overcoming Challenges
USFDA Inspection: At Marksans with 5 inspectional observations
Standardizing Approval Formats: CoPP and WHO GMP certificates
Regulatory Landscape for Medical Device Companies in India
Nestle India Under Fire for Allegedly Adding Excess Sugar to Baby Food
The Rise of Specialization in Pharmacy Education: Dr B Suresh
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
